نتائج البحث - "Jarque, Isidro"

العلاقة: https://doi.org/10.1046/j.1365-2141.2001.03144.xTest; García‐Sanz, R., Montoto, S., Torrequebrada, A., De Coca, A. G., Petit, J., Sureda, A., . & Miguel, J. F. S. (2001). Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases. British journal of haematology, 115(3), 575-582. https://doi.org/10.1046/j.1365-2141.2001.03144.xTest; http://hdl.handle.net/10366/155313Test

الإتاحة: https://doi.org/10.1046/j.1365-2141.2001.03144.xTest
http://hdl.handle.net/10366/155313Test

View record in BASE

6

Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphoma

المصدر: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Recercat. Dipósit de la Recerca de Catalunya
instname
Cancer Medicine
Dipòsit Digital de la UB
Universidad de Barcelona

مصطلحات موضوعية: Oncology, Male, Cancer Research, Limfomes, Time Factors, Databases, Factual, Follicular lymphoma, Limfomes -- Tractament, Kaplan-Meier Estimate, Stem cells, Autologous Stem Cell Trasplantation, 0302 clinical medicine, Autologous stem-cell transplantation, Risk Factors, Registries, Lymphoma, Follicular, Original Research, education.field_of_study, Hazard ratio, Middle Aged, Treatment Outcome, 030220 oncology & carcinogenesis, PFS 24, Disease Progression, Rituximab, Female, Lymphomas, Immunotherapy, Cèl·lules mare, medicine.drug, Adult, medicine.medical_specialty, CR 30, Adolescent, Endpoint Determination, Follicular Lymphoma, Population, Antineoplastic Agents, Transplantation, Autologous, Disease-Free Survival, 03 medical and health sciences, Young Adult, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, Progression-free survival, education, Aged, Proportional Hazards Models, Retrospective Studies, Autologous stem cell trasplantation, business.industry, Proportional hazards model, Surrogate endpoint, Clinical Cancer Research, medicine.disease, Surgery, Spain, business, 030215 immunology, Stem Cell Transplantation

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84121ae638da5bc475b165590ab27d17Test
http://hdl.handle.net/2445/124034Test

7

Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation

المؤلفون: Vallejo, Carlos, Batlle, Montserrat, Vazquez, Lourdes, Solano, Carlos, Sampol, Antonia, Duarte, Rafael, Hernández, Dolores, López, Javier, Rovira Tarrats, Montserrat, Jiménez, Santiago, Valcárcel, David, Belloch, Vicente, Jiménez, Mónica, Jarque, Isidro, Subcommittee of Non-Infectious Complications of the Grupo Español de Trasplante Hematopoyético (GETH)

المصدر: Haematologica Vol. 99 Issue 10: pp. 1632-1637
Dipòsit Digital de la UB
Universidad de Barcelona
RODERIC. Repositorio Institucional de la Universitat de Valéncia
instname
Recercat. Dipósit de la Recerca de Catalunya

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Liver Iron Concentration, Iron Overload, medicine.medical_treatment, Population, Stem cells, Hematopoietic stem cell transplantation, Iron Chelating Agents, Benzoates, Gastroenterology, Young Adult, chemistry.chemical_compound, Internal medicine, medicine, Humans, Transplantation, Homologous, Adverse effect, education, Prospective cohort study, Aged, education.field_of_study, Creatinine, business.industry, Deferasirox, Hematopoietic Stem Cell Transplantation, Hematologic diseases, Transfusion Reaction, Articles, Hematology, Middle Aged, Triazoles, Surgery, Transplantation, Treatment Outcome, chemistry, Malalties hematològiques, Ferritins, Female, Cèl·lules mare, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4c982e4fed80bfdb628c85f7cd648e2Test
http://hdl.handle.net/10550/44435Test

8

دورية أكاديمية

Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia

مصطلحات موضوعية: Adult, Aged, Antibodies, Monoclonal, Dose-Response Relationship, Drug, Female, Humans, Immunoglobulin G, Male, Middle Aged, Purpura, Thrombocytopenic, Idiopathic, Recombinant Proteins

العلاقة: Blood vol:120 issue:18 pages:3670-6; https://lirias.kuleuven.be/handle/123456789/380026Test; http://bloodjournal.hematologylibrary.org/cgi/pmidlookup?view=long&pmid=22915649Test

الإتاحة: https://lirias.kuleuven.be/handle/123456789/380026Test
http://bloodjournal.hematologylibrary.org/cgi/pmidlookup?view=long&pmid=22915649Test

View record in BASE

النص الكامل

9

Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study)

المؤلفون: Cristina Loriente, Inmaculada Pérez, Montserrat López Rubio, Ana Cristina Godoy, María del Carmen Losada Castillo, Carolina Cuellar-García, Eduardo Ríos, Lucrecia Yáñez, Maria Dolores Garcia Malo, Ana Lario, Pau Abrisqueta, Julio Delgado, Mª José Berruezo, Alicia Smucler Simonovich, Alicia Rodríguez, Rafael Ramos, Miguel Villanueva, José Mª Arguiñano Pérez, Daniel Acha, Margarita Fernández de la Mata, Isidro Jarque, Javier Loscertales, Jose Luis Bello, Santiago Osorio, Paloma Martin, Angel Ramirez Payer, Macarena Ortiz, Ernesto Pérez Persona, Rubén Fernández Álvarez, Aima Lancharro Anchel, Jose Angel Hernandez-Rivas, Miguel Fernández-Zarzoso, Ana Célia Carneiro Oliveira, Patricia Baltasar, Angeles Medina, Mª Jesús Vidal Manceñido, Alexia Suarez, Ricardo García Muñoz, María José Terol, Fernando De Marco

المساهمون: [Abrisqueta, Pau] Hosp Univ Vall dHebron, Barcelona, Spain, [Loscertales, Javier] Hosp Univ La Princesa, IIS IP, Madrid, Spain, [Jose Terol, Maria] Hosp Clin Univ Valencia, Valencia, Spain, [Ramirez Payer, Angel] Hosp Univ Cent Asturias, Oviedo, Spain, [Ortiz, Macarena] Hosp Reg Univ Malaga, Malaga, Spain, [Perez, Inmaculada] Hosp Virgen de la Victoria, Malaga, Spain, [Cuellar-Garcia, Carolina] Hosp Santa Creu & Sant Pau, Barcelona, Spain, [Fernandez de la Mata, Margarita] Hosp Univ Reina Sofia, Cordoba, Spain, [Rodriguez, Alicia] Hosp Univ Virgen Macarena, Seville, Spain, [Lario, Ana] Hosp Univ Ramon y Cajal, Madrid, Spain, [Delgado, Julio] Hosp Clin Barcelona, Barcelona, Spain, [Godoy, Ana] Hosp Univ Miguel Servet, Zaragoza, Spain, [Arguinano Perez, Jose Ma] Complejo Hosp Navarra, Pamplona, Spain, [Berruezo, Ma Jose] Hosp Univ Jerez, Cadiz, Spain, [Oliveira, Ana] ICO Hosp, Lhospitalet De Llobregat, Spain, [Hernandez-Rivas, Jose-Angel] Hosp Univ Infanta Leonor, Madrid, Spain, [Dolores Garcia Malo, Maria] Hosp Gen Univ Morales Meseguer, Murcia, Spain, [Medina, Angeles] Hosp Costa del Sol, Malaga, Spain, [Garcia Martin, Paloma] Hosp Univ Virgen de las Nieves, Granada, Spain, [Osorio, Santiago] Hosp Gen Univ Gregorio Maranon, Madrid, Spain, [Baltasar, Patricia] Hosp Univ La Paz, Madrid, Spain, [Fernandez-Zarzoso, Miguel] Hosp Univ Dr Peset, Valencia, Spain, [Marco, Fernando] Hosp Univ Basurto, Bilbao, Bizkaia, Spain, [Vidal Mancenido, Ma Jesus] Hosp Univ Leon, Leon, Spain, [Smucler Simonovich, Alicia] Hosp Univ El Bierzo, Leon, Spain, [Lopez Rubio, Montserrat] Hosp Univ Principe Asturias, Madrid, Spain, [Jarque, Isidro] Hosp Univ La Fe, Valencia, Spain, [Suarez, Alexia] Hosp Univ Gran Canaria Doctor Negrin, Las Palmas Gran Canaria, Spain, [Fernandez Alvarez, Ruben] Hosp Cabuenes, Gijon, Spain, [Lancharro Anchel, Aima] Hosp Gen Univ Castellon, Castellon de La Plana, Spain, [Rios, Eduardo] Hosp Univ Virgen de Valme, Seville, Spain, [Losada Castillo, Maria del Carmen] Hosp Univ Insular Gran Canarias, Las Palmas Gran Canaria, Las Palmas, Spain, [Perez Persona, Ernesto] Hosp Txagorritxu, Vitoria, Spain, [Garcia Munoz, Ricardo] Hosp San Pedro, Logrono, Spain, [Ramos, Rafael] Hosp Univ Badajoz, Badajoz, Spain, [Yanez, Lucrecia] Hosp Univ Marques de Valdecilla, Santander, Spain, [Bello, Jose Luis] Hosp Clin Univ Santiago CHUS, Santiago De Compostela, A Coruna, Spain, [Loriente, Cristina] Med Dept Hematol Janssen Cilag SA, Madrid, Spain, [Acha, Daniel] Med Dept Hematol Janssen Cilag SA, Madrid, Spain, [Villanueva, Miguel] Med Dept Hematol Janssen Cilag SA, Madrid, Spain, Janssen-Cilag S.A

المصدر: Clinical lymphoma, myeloma & leukemia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
r-FISABIO. Repositorio Institucional de Producción Científica
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Dipòsit Digital de la UB
Universidad de Barcelona

مصطلحات موضوعية: Cancer Research, Chronic lymphocytic leukemia, Effectiveness, Relapsed/refractory (R/R), chemistry.chemical_compound, Fludarabine, Piperidines, Protein kinases, immune system diseases, hemic and lymphatic diseases, Open-label, Chemoimmunotherapy, Hazard ratio, Ibrutinib, First-line, Hematology, Chronic lymphocytic leukemia (CLL), Oncology, Tolerability, Bendamustine, IGHV@, Rituximab, medicine.drug, medicine.medical_specialty, Efficacy, Phase-3, Internal medicine, medicine, Humans, Leucèmia limfocítica crònica, Progression-free survival, neoplasms, Cyclophosphamide, Aged, Retrospective Studies, Chlorambucil, business.industry, Adenine, Cll patients, medicine.disease, Leukemia, Lymphocytic, Chronic, B-Cell, Proteïnes quinases, Pyrimidines, chemistry, Real-world, Spain, Pyrazoles, Chronic lymphocytic leukemia (CLL), Effectiveness, First-line, Ibrutinib, Real-world, Relapsed/refractory (R/R), Therapy, business, Progressive disease

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46c4f2a1bd607572095c4a75307637b0Test
https://pubmed.ncbi.nlm.nih.gov/34511320Test

تنقيح النتائج